IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 190 filers reported holding IMPAX LABORATORIES INC in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,000 | +33.3% | 203 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,000 | -25.0% | 203 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $4,000 | +33.3% | 203 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $3,000 | +50.0% | 203 | +22.3% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | -66.7% | 166 | -33.3% | 0.00% | -66.7% |
| Q3 2016 | $6,000 | 0.0% | 249 | +20.9% | 0.00% | 0.0% |
| Q2 2016 | $6,000 | +20.0% | 206 | +19.8% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | -28.6% | 172 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $7,000 | +16.7% | 172 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,000 | -25.0% | 172 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $8,000 | 0.0% | 172 | -3.9% | 0.01% | 0.0% |
| Q1 2015 | $8,000 | +60.0% | 179 | +4.1% | 0.01% | +66.7% |
| Q4 2014 | $5,000 | 0.0% | 172 | -15.3% | 0.00% | -25.0% |
| Q3 2014 | $5,000 | 0.0% | 203 | +11.5% | 0.00% | +33.3% |
| Q2 2014 | $5,000 | 0.0% | 182 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $5,000 | – | 182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
| NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
| Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
| MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
| SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
| BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
| Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
| Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
| Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
| Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |